Showing results (91-100 of 172) with videos related to
Sort By:
Pageof 18
Nature|May 5, 2009
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphomaMara Compagno, Wei Keat Lim, Adina Grunn, et al.Leukemia & Lymphoma|April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaSarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.Haematologica|February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.Infectious Agents and Cancer|November 15, 2021
Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphomaParag Mahale, Jason Nomburg, Joo Y Song, et al.The American Journal of Surgical Pathology|March 27, 2004
CD44 loss in gastric stromal tumors as a prognostic markerElizabeth Montgomery, Susan C Abraham, Cyril Fisher, et al.Clinical Chemistry|August 22, 2020
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine LearningHe S Yang, Yu Hou, Ljiljana V Vasovic, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
HIV-associated non-Hodgkin lymphoma tumor-microenvironment axes differ by EBV status across cellular originsAmy Chadburn, Maria Montserrat Aguilar Hernandez, Joanne Dai, et al.Journal of General Internal Medicine|November 22, 2023
Improved Utilization of Serial Testing Without Increased Admissions after Implementation of High-Sensitivity Troponin I: a Controlled Retrospective Cohort StudyLaura Warren, Brett G Fischer, Amos Shemesh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphomaJia Ruan, Peter Martin, Richard R Furman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphomaJohn P Leonard, Morton Coleman, Lale Kostakoglu, et al.Pageof 18